Login to Your Account



Let the Mad Scramble Begin!

Abstracts Go Public, Stocks Keep Hopping Ahead of ASCO

By Jennifer Boggs


Monday, May 24, 2010
As an estimated 30,000 cancer specialists prepare to converge on the city of Chicago in a couple of weeks for the so-called "Super Bowl of Cancer" - or, as analysts at Wedbush PacGrow Life Sciences put it, "the most important and most unmanageable" of the annual biotech meetings - investors already have been placing their bets on companies expected to wow attendees at this year's American Society of Clinical Oncology meeting. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription